explore -WSS

explore

author：fashion 2025-10-01 15:40:21 - browse：65

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： A Q&A with Aletha Maybank, AMA’s chief health equity officer

hotspot

WSS

Obesity now affects over 1 billion people worldwide, study finds

Influencer to be charged after chaos erupts in New York City's Union Square

In search for therapies for solid tumors, companies turn to claudin

What Mike Pence has said that could be used in a Donald Trump trial

Clinical trials giant ICON acquires HumanFirst

What the cancer research community can learn from the Covid response

focus

explore

focus

23andMe had bad news about my health. I wish a person had delivered it

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

State Dept. review finds Biden bears some blame for Afghanistan failures

Nearly two

BioMarin wins approval for gene therapy to treat hemophilia A

Clinical trials giant ICON acquires HumanFirst

The cancer drug shortage isn’t new — and neither are the solutions

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

George Santos makes 1st court appearance after pleading not guilty to 13 counts

OTC birth control: A brief history of over the counter pill design

focus

Biden calls for immediate release of Niger's president amid apparent coup

An inside look at PIPEs, biotech's buzzy new financing tool

How to address the problem of discarded donor organs

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

ProMED, early warning system on disease outbreaks, in peril

Verily hires former Apple Health leader as chief scientific officer

hotspot

Wikipedia

explore

focus